Searched for
GENERIC RISPERIDONE
Small-cap stocks: Riskier, without a doubt. But time to be contrarian? 6 small-caps from different sectors to keep an eye onWhy look at small-caps when there are many large-cap stocks available at decent valuations? But then, a counter-question: When is it a good...- Lupin launches generic injection in US with 180-day exclusivityIn an exciting development for mental health treatment, Lupin has introduced a generic version of a medication for schizophrenia and bipola...
- Lupin gets USFDA nod for generic risperidone extended-release injectable suspensionLupin Ltd. secured USFDA approval for its generic risperidone extended-release injectable suspension, a treatment for schizophrenia and bip...
- Zydus, Teva end patent disputesAhmedabad-based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients (APIs)...
- Aussie nod for Ranbaxy's anti-psychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag's anti-schizop...
- Ranbaxy gets Australia nod for antipsychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag’s anti-schizop...
- Aurobindo Pharma surges 13% on USFDA nodShares of Aurobindo Pharma extended gains after the company received US administration's approval for Sertraline Hydrochloride oral concent...
- Stocks to watch: SBI, Reliance, Zydus CadillaEquities are likely to open lower on Monday following meltdown in overseas markets on fears of slow-down in global economy and recession in...
- Zydus drags Teva to court for antitrust violationsZydus Cadila, an Ahmedabad-based pharmaceutical company, has taken Teva Pharmaceuticals, the world’s largest generic drug maker, to court i...
- Lupin's Japanese arm gets nod for 10 productsLupin's Japanese subsidiary Kyowa Pharma has received approvals for 10 products and expects to launch these in July 2008 post NHI listing.
- Ranbaxy got USFDA nod for RisperdalThe country's largest drugmaker Ranbaxy Laboratories received the US food and drug administration (USFDA) nod to sell generic version of Ri...
- Ranbaxy to market second licensed generic in CanadaThe generic fentanyl patch is sold under Ranbaxy's label 'Ran Fentanyl Transdermal System', used for management of persistent and chronic p...
Load More- Zydus, Teva end patent disputes
